A large prostate cancer tissue microarray study identified granular cytoplasmic SFRP4 over-expression positively correlated with aggressive disease, early PSA-recurrence, and genomic instability in ERG negative prostate cancers [174]. This evidence concerns the gene SFRP4 and prostate carcinoma.